Drug – bio-affecting and body treating compositions – Lymphokine
Reexamination Certificate
2005-01-11
2005-01-11
Kemmerer, Elizabeth (Department: 1647)
Drug, bio-affecting and body treating compositions
Lymphokine
C424S198100, C514S002600, C514S012200, C530S300000, C530S350000, C530S351000, C530S399000
Reexamination Certificate
active
06841147
ABSTRACT:
Novel stem cell factors, oligonucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders involving blood cells are also disclosed.
REFERENCES:
patent: 4847325 (1989-07-01), Shadle et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 5767074 (1998-06-01), Besmer et al.
patent: 5772992 (1998-06-01), Bauer et al.
patent: 5786323 (1998-07-01), Nakahata
patent: 6204363 (2001-03-01), Zsebo et al.
patent: 0 845 268 (1998-06-01), None
patent: 62-223126 (1987-10-01), None
patent: WO 9506112 (1995-03-01), None
patent: WO 9818924 (1998-05-01), None
patent: WO 9823773 (1998-06-01), None
Groopman et al. Hematopoietic growth factors. N Engl J Medicine 321(21): 1449-1459, 1989.*
Brenner, S.E. Errors in genome function. Trends in Genetics 15(4): 132-133, 1999.*
Bork et al. Go hunting in sequence databases but watch out for the traps. Trends in Genetics. 12(10): 425-427, 1996.*
Wells. J.A. Additivity of mutational effects in proteins. Biochemistry 29 (37): 8509-8517, 1990.*
Ngo et al. Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994.*
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotech 18(1): 34-39, 2000.*
Bork, A. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res 10: 398-400, 2000.*
Doerks et al. Protein annotation: detective work for function prediction. Trends in Genetics 14(6): 248-250, 1998.*
Smith et al. The challenges of genome sequence annotation or “The devil is in the details”. Nature Biotech 15: 1222-1223, 1997.*
Corti et al.,Exp. Neurol., 177: 443-452 (2002).
Costa et al.,J. Exp. Med., 183: 2681-2686 (1996).
Kawakami et al.,J. Invest. Dermatol., 118: 471-478 (2002).
Bodine et al., “Combination of Interleukin 3 and 6 Preserves Stem Cell Function in Culture and Enhances Retrovirus-Mediated Gene Transfer Into Hematopoietic Stem Cells,”Proc. Nat'l Acad. Sci., USA, 6:8897-8901 (1989).
Broxmeyer et al., “Cell-Free Granulocyte Colony Inhibiting Activity Derived from Human Polymorphonuclear Neutrophils,”Exp. Hemat., 5:87-102 (1977).
Dexter, T.M., “Haemopoietic Growth Factors,”British Medical Bulletin, 45(2):337-349 (1989).
Dick et al., “Introduction of New Genes into Hematopoietic Stem Cells,”J. Cell. Biol., Supplement 11A, p. 187 (1987) (Abstract D 026).
Dick et al., “Introduction of Selectable Gene into Primitive Stem Cells Capable of Long-Term Reconstitution of the Hemopoietic System of W/WvMice,”Cell, 42:71-79 (1985).
Hiraoka et al., “Further Characterization of the Biological Properties of Human Hematopoietic Survival and Growth Factor,”Expl. Cell. Biol., 57:27-34 (1989).
Hiraoka et al., “Human Hematopoietic Survival and Growth Factor,”Cell Biology International Reports, 10(5):347-355 (1986).
Hiraoka et al., “Monoclonal Antibodies Against Human Hematopoietic Survival and Growth Factor,”Biomed. Biochim. Acta, 46(5):419-427 (1987).
Hiraoka et al., “Production of Human Hematopoietic Survival and Growth Factor by a Myeloid Leukemia Cell Line (KPB-M15) and Placenta as Detected by a Monoclonal Antibody,”Cancer Research, 47:5025-5030 (1987).
Hollands, “Differentiation of Embryonic Haemopoietic Stem Cells from Mouse Blastocysts Growth in Vitro,”Development, 102:135-141 (1988).
Humphries et al., “Aplastic Anemia and Stem Cell Biology,”Aplastic Anemia: Stem Cell Biology and Advances in Treatment, Alan R. Liss, Inc., New York, New York, pp. 3-12 (1984).
Jones et al., “Cyclic Hematopoiesis: Animal Models,”Exp. Hematol., 11(7):571-580 (1983).
Kamamoto et al., “Establishment of Two Ph1Chromosome-Positive Cell Lines, KPB-M8 and KPB-M15,”Jpn. J. Clin. Oncol., 16(2):107-115 (1986).
Kriegler et al., “Partial Purification and Characterization of a Growth Factor for Macrophage Progenitor Cells with High Proliferative Potential in Mouse Bone Marrow,”Blood, 60(2):503-508 (1982).
Langley et al., “Soluble Stem Cell Factor in Human Serum,”Blood, 81(3):656-660 (1993).
Lyman et al., “Molecular Cloning of a Ligand for the flt3/flk-2 Tyrosine Kinase Receptor: A Proliferative Factor for Primitive Hematopoietic Cells,”Cell, 75:1157-1167 (1993).
March et al., “Cloning, Sequence and Expression of Two Distinct Human Interleukin-1 Complementary DNAs,”Nature, 315:641-647 (1985).
Martin et al., “Primary Structure and Functional Expression of Rat and Human Stem Cell Factor DNAs,”Cell, 63:203-211 (1990).
Martin, P., “HEL Cells: A New Human Erythroleukemia Cell Line with Spontaneous and Induced Globin Expression,”Science, 216:1233-1235 (1982).
McDermott et al., “Inhibition of Cell Proliferation in Renal Failure and Its Significance to the Uraemic Syndrome: A Review,”Scot. Med. J., 20:317-327 (1975).
McNiece et al., “Studies on the Myeloid Synergistic Factor From 5637: Comparison with Interleukin -1 Alpha,”Blood73(4):919-923 (1989).
Moore, M.A.S., “Clinical Implications of Positive and Negative Hematopoietic Stem Cell Regulators,”Blood, 78(1):1-19 (1991).
Mori et al., “Myeloproliferative Sarcoma Virus Stimulates Pluripotent Hematopoietic Stem Cells and Provokes Tumoral Transformation of the Hematopoietic Microenvironment in Vitro,”Leukemia Research, 7(1):77-86 (1983).
Nabel et al., “Inducer T Lymphocytes Synthesize a Factor That Stimulates Proliferation of Cloned Mast Cells,”Nature, 291:332-334 (1981).
Qui et al., “Primary Structure of c-kit: Relationship with the CSF-1/PDGF Receptor Kinase Family-Oncogenic Activation of v-kit Involves Deletion of Extracellular Domain and C Terminus,”EMBO J., 7(4):1003-1011 (1988).
Schrader, “Role of a Single Haemopoietic Growth Factor in Multiple Proliferative Disorders of Haemopoietic and Related Cells,”Lancet, 2:133-137 (1984).
Spangrude et al., “Purification and Characterization of Mouse Hematopoietic Stem Cells,”Science, 214:58-62 (1988).
Watson et al., “Molecular Cloning of the Polypeptide Factors That Stimulate Growth, Maturation, and Function of Blood Cells60-66,”Molecular Biology of the Gene, Fourth Edition, pp. 983-992 (1987).
Welte et al., “Recombinant Human Granulocyte Colony-Stimulating Factor,”J. Exp. Med., 165:941-948 (1987).
Yarden et al., “Human Proto-Oncogene c-kit: a New Cell Surface Receptor Tyrosine Kinase for an Unidentified Ligand,”EMBO J., 6(11):3341-3351 (1987).
Zajicek, “Inflammation Initiates Cancer by Depleting Stem Cells,”Medical Hypotheses, 18:207-219 (1985).
Zsebo et al. “Effects of Hematopoietin-1 and Interleukin 1 Activities on Early Hematopoietic Cells of the Bone Marrow,”Blood, 71(4):962-968 (1988).
Zsebo et al., “Stem Cell Factor Is Encoded at the SI Locus of the Mouse and Is the Ligand for the c-kit Tyrosine Kinase Receptor,”Cell, 63:213-224 (1990).
Bosselman Robert A.
Martin Francis H.
Suggs Sidney V.
Zsebo Krisztina M.
Amgen Inc.
Bunner Bridget E.
Kemmerer Elizabeth
Marshall & Gerstein & Borun LLP
LandOfFree
Stem cell factor compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stem cell factor compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stem cell factor compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3419687